Medical Management of Suspected Spontaneous Bacterial Peritonitis
Start empirical IV antibiotics immediately once ascitic fluid PMN count exceeds 250/mm³, using IV cefotaxime 2g every 12 hours for community-acquired SBP, or carbapenems for nosocomial/critically ill patients, while simultaneously administering IV albumin to reduce mortality. 1
Immediate Diagnostic Steps
Before initiating antibiotics, perform these critical actions:
- Diagnostic paracentesis immediately upon suspicion of SBP—even without symptoms if the patient is emergently hospitalized with cirrhosis and ascites 1
- Bedside inoculation of at least 10 mL ascitic fluid into aerobic and anaerobic blood culture bottles (increases culture sensitivity to >90%) 1
- Simultaneous blood cultures to increase organism isolation 1
- Obtain ascitic fluid PMN count stat—diagnosis confirmed if >250/mm³ 1
Critical timing consideration: In cirrhotic patients with septic shock, mortality increases by 10% for every hour's delay in antibiotic initiation 1. Do not wait for culture results.
Antibiotic Selection Algorithm
Community-Acquired SBP (First-Line)
- IV cefotaxime 2g every 12 hours in settings where multidrug-resistant organisms (MDROs) are not prevalent 1
- Third-generation cephalosporins historically achieve ~90% resolution rates 1
High-Risk for MDROs (Broader Coverage Required)
Use carbapenems as initial therapy for patients with: 1
- Nosocomial infection (hospital-acquired)
- Recent hospitalization
- ICU admission/critically ill status
- Septic shock presentation
Rationale: MDROs now represent 35% of infections in cirrhotic patients, with shift from gram-negative (E. coli, Klebsiella) toward gram-positive and resistant organisms 1. Inappropriate initial antimicrobial therapy in septic shock increases death risk 10-fold 1. Carbapenems demonstrate higher SBP resolution and lower mortality in nosocomial and critically ill patients 1.
Essential Adjunctive Therapy
IV albumin administration must accompany antibiotics—this combination has been shown to decrease azotemia development and reduce hospitalization-related mortality 2. This addresses the cytokine cascade and nitric oxide generation that contributes to the 30% hospitalization mortality despite infection control 2.
Antibiotic Stewardship
- Narrow coverage as soon as culture results available 1
- Shortest duration possible to prevent resistance 1
- Treatment duration: 5 days for uncomplicated SBP 3
- If persistent symptoms or PMN >250/mm³ after treatment, broaden spectrum and search for secondary peritonitis 3
Critical Pitfalls to Avoid
Do not delay paracentesis for coagulopathy concerns—prolonged PT is expected in cirrhosis and is NOT a contraindication 4. Only consider platelet transfusion if <40,000-50,000/μL 4
Exclude surgical abdomen: Patients with focal intra-abdominal pathology (diverticulitis, cholecystitis) may have PMN >250/mm³ but require surgical consultation, not SBP treatment 1
Do not use cephalosporins blindly in nosocomial settings—the changing epidemiology toward MDROs makes them increasingly ineffective 5
Recognize asymptomatic presentation: Up to one-third of SBP patients have no symptoms or present only with encephalopathy/AKI 1
Prophylaxis Considerations
For patients surviving SBP episode or at high risk, secondary prophylaxis with norfloxacin 400mg daily should continue until ascites resolves or liver transplantation 2. Patients with GI hemorrhage should receive ceftriaxone prophylactically 4.